Mandatory Baxter Infusion Pump Recall Will Cost Up To $600 Million
This article was originally published in The Gray Sheet
Executive Summary
Baxter will recall all of its Colleague infusion pumps on the U.S. market at an initial cost of up to $600 million, the firm disclosed May 3